Regulatorische Updates

The Gwangjin‑gu Pharmacists Association voiced worries to a lawmaker about the government's plan to broaden home delivery of prescription medicines, citing safety and regulatory issues.

The Korean Pharmacy Association for Health Society urges a shift to a public, non‑profit telemedicine platform ahead of the December 24 medical law amendment.

The society seeks to halve the national dyslipidemia screening cycle from four to two years and push for insurance and primary‑care policy updates.

A bill introduced by lawmaker Choi Hyuk‑jin aims to include security staff as protected persons, reduce liability for lawful restraint, and mandate security equipment, responding to over 3,300 ER disturbance reports in five years.

Lawmakers and health NGOs held a discussion on improving operating‑room CCTV to protect patient rights, marking ten years since Kwon Dae‑hee’s death.

Health and Welfare Committee Chair Lee Man-hee and Agriculture Committee Chair Seo Sam-seok co‑hosted a forum to address medical gaps and care burdens in rural areas.

The Korean Pharmaceutical Association launched an emergency response committee to oppose the government's plan to expand prescription drug delivery for telemedicine, announcing coordinated action across regional branches.

Jeonnam Gwangju Suncheon University and Gyeongbuk Gyeongguk University vie for a 100‑seat national medical school, sparking parliamentary debate and mixed local reactions.

Korea's Health Insurance Review & Assessment Service released a list of 14,013 drugs for price‑ceiling re‑evaluation, excluding 1,576 items, leaving 12,437 for review.

Lawmaker Jeon Jong-deok and the Korean Confederation of Trade Unions condemned the lack of budget for care‑worker pay and urged the National Assembly to allocate more funds.

A Korean public petition has quickly amassed over 25,000 signatures, urging the government to withdraw the expanded drug‑delivery policy linked to telemedicine before the Oct 3 deadline.

From Nov 27, Korea’s Ministry of Health and Welfare will regulate the ‘one pharmacist, one pharmacy’ principle for both opening and operating pharmacies, with penalties for operating multiple outlets.